Synthesis and Anti-hypoxic Activity Research of Daidzein Derivatives
Chemical and Pharmaceutical Bulletin · 08.05.2025 · 73 (5) · 434-444
DOI: 10.1248/cpb.c25-00014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 08.05.2025. Verfasst von Xiaohan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, People's Republic of China. Hauptthemen laut MEDLINE: Isoflavones, Hypoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
To search for safe and efficient anti-hypoxia active molecules, 27 derivatives were synthesized by introducing aminoalkyl groups at daidzein's position-7 and position-8. The structures of these derivatives were confirmed by 1H-NMR, 13C-NMR, and mass spectrometry. The anti-hypoxia activity was evaluated in vitro using a cell hypoxia model established with the AnaeroPack-anaero. The results showed that 9 compounds significantly enhanced cell viability under hypoxic conditions, with compounds 2a, 2b, 4d, 5a, and 5d exhibiting in vitro anti-hypoxia activity significantly superior to daidzein. And the drug-like properties prediction results of the target compounds indicated that compounds 2a, 2b, 4d, 5a, and 5d may also demonstrate favorable pharmacokinetic properties. Further, the anti-hypoxia activity in vivo of these 5 derivatives were evaluated via normobaric hypoxia and hypobaric hypoxia models. The results indicated that all of the 5 compounds extended the survival time of mice under normobaric hypoxia to varying degrees, and they also alleviated oxidative stress damage to the brain and heart of mice under hypobaric hypoxia. Among these, compound 2a demonstrated superior anti-hypoxia activity both in vitro and in vivo compared to daidzein, making it worthy of further study as a potential candidate for an anti-hypoxia drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, People's Republic of China.
- Beijing Institute of Radiation Medicine, Beijing 100850, People's Republic of China.
- College of Pharmacy Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.
Zitieren
APA
Liu, X., Liu, X., Zheng, W., Xu, J., Chen, T., Peng, T., Liu, R., Liu, S., Wang, L., & Zhang, S. (2025). Synthesis and Anti-hypoxic Activity Research of Daidzein Derivatives. Chemical and Pharmaceutical Bulletin, 73(5), 434-444. https://doi.org/10.1248/cpb.c25-00014
Vancouver
Liu X, Liu X, Zheng W, Xu J, Chen T, Peng T, et al. Synthesis and Anti-hypoxic Activity Research of Daidzein Derivatives. Chemical and Pharmaceutical Bulletin. 2025;73(5):434-444. doi:10.1248/cpb.c25-00014
BibTeX
@article{Liu2025,
author = {Liu, Xiaohan and Liu, Xinru and Zheng, Wenteng and Xu, Jing and Chen, Tingting and Peng, Tao and Liu, Ruixin and Liu, Shuchen and Wang, Lin and Zhang, Shouguo},
title = {Synthesis and Anti-hypoxic Activity Research of Daidzein Derivatives},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2025},
volume = {73},
number = {5},
pages = {434--444},
doi = {10.1248/cpb.c25-00014}
}
EUVIMED